GL Pharm Tech지엘팜텍
204840 · KOSDAQ · ₩204840 · 지엘팜텍
- Market cap
- ₩56B
- Enterprise value
- ₩73B
- P/E
- 1,502.2×
- P/B
- 2.8×
- Dividend yield
- 0.0%
- ROE
- 0.2%
- Net margin
- 0.1%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−45.4% from the high
₩3,300Today: ₩3,300 – ₩3,590₩6,555
Returns
- 1W−10.5%
- 1M−17.1%
- 3M−12.0%
- 6M−32.6%
- YTD−34.4%
- 1Y−40.6%
- Volume today
- 41,096
- 1.7× the 20-day average
- Traded today
- ₩140M
- Listed shares
- 15,509,801
- EPS (12 months)
- ₩2
- Earnings yield 0.1%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Normal- BuzzNormalBuzz 49 of 100 (50 is a normal day for this stock).
- MomentumWeak-19.7% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
GL Pharm Tech stock overview
GL Pharm Tech (지엘팜텍, KRX: 204840) is listed on KOSDAQ, in the Retail & Trade sector. The company is a Korean pharmaceutical firm focused on pharmaceutical research and development services and pharmaceutical sales and marketing, operating through its consolidated subsidiary JL Pharma, which manufactures and sells medicines. Its shares closed at ₩3,580 on Oct 26, 2026, down 0.42% on the day, giving it a market value of ₩56B.
Key facts
- Market cap
- ₩56B
- Sector
- Retail & Trade
- Latest price change
- −0.42%
- As of
- Oct 26, 2026
- Main business
- The company is a Korean pharmaceutical firm focused on pharmaceutical research and development services and pharmaceutical sales and marketing, operating through its consolidated subsidiary JL Pharma, which manufactures and sells medicines.
Quick answers about GL Pharm Tech
- What does GL Pharm Tech do?
- The company is a Korean pharmaceutical firm focused on pharmaceutical research and development services and pharmaceutical sales and marketing, operating through its consolidated subsidiary JL Pharma, which manufactures and sells medicines. Its products include prescription and over-the-counter drugs, such as the pain reliever Alsaxen and the ulcer treatment Pamotidine, along with traded products sold through business-to-business channels and royalty and technology fee income from licensing its drug formulation technologies to domestic and overseas pharmaceutical companies. Its customers are pharmaceutical companies, with products distributed through hospitals, clinics, and pharmacies.
- What is the market cap of GL Pharm Tech?
- The market capitalisation of GL Pharm Tech was ₩56B at the close on Oct 26, 2026.
- Who are the largest shareholders of GL Pharm Tech?
- According to the latest official filings, the largest reported holders are W Science (29.81%, as of Aug 6, 2026); Park Sang-tae (0.03%, as of Aug 6, 2026).
- When is the next earnings report from GL Pharm Tech?
- Korean companies rarely announce results dates in advance. Based on when GL Pharm Tech filed the same report in past years, its next 3q results is expected between Nov 10, 2026 and Nov 14, 2026.
Company profile
The company is a Korean pharmaceutical firm focused on pharmaceutical research and development services and pharmaceutical sales and marketing, operating through its consolidated subsidiary JL Pharma, which manufactures and sells medicines. Its products include prescription and over-the-counter drugs, such as the pain reliever Alsaxen and the ulcer treatment Pamotidine, along with traded products sold through business-to-business channels and royalty and technology fee income from licensing its drug formulation technologies to domestic and overseas pharmaceutical companies. Its customers are pharmaceutical companies, with products distributed through hospitals, clinics, and pharmacies.
Written by AI from the company's latest annual report.
- Korean name
- 지엘팜텍
- Sector
- Retail & Trade
- Themes
- Pharmaceuticals
- CEO
- 김용일, 진성필
- Founded
- Jul 2014
- Listed
- Nov 2014
- Listed shares
- 15,509,801
- Fiscal year ends
- Month 12
- Website
- www.glpt.co.kr
Similar companies
- Samsung C&T028260 · ₩47T₩292,000+1.39%
- POSCO International047050 · ₩8.7T₩49,550−3.79%
- Youngone111770 · ₩3T₩67,400−2.32%
- ISC095340 · ₩3T₩140,600−5.19%
- Dong SUH Companies026960 · ₩2.7T₩27,300−1.44%
- SK Gas018670 · ₩2.3T₩251,000−3.09%
- Shinsegae004170 · ₩2.3T₩245,000−3.92%
- Lotte Shopping023530 · ₩2.3T₩81,400−2.63%
Recent filings
See all- Amended: Major sales or supply contractSep 21, 2026
- Major management matter relevant to investorsAug 21, 2026
- Half-year report (Jun 2026)Aug 13, 2026
- Trading haltAug 10, 2026
- 5%+ holding reportAug 6, 2026
Titles in Korean until English translations are added.
Also known as: GL Pharm Tech / 지엘팜텍 / 204840 / KRX:204840
Source: KRX statistical information